Clinical Trials
23 trialsContinuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
National Institutes of Health Clinical Center (CC)
Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial
First Affiliated Hospital Xi'an Jiaotong University
SAPPHIRE-MM
University Hospital Heidelberg
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
Tongji Hospital
Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma
Universidad Complutense de Madrid
Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma
Universidad Complutense de Madrid
Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
Peking Union Medical College Hospital
MFM
Medical College of Wisconsin
ENTRAIDANT
Assistance Publique - Hôpitaux de Paris
Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients
University of Salamanca
r/r MM
Guangzhou Bio-gene Technology Co., Ltd
CAR-T
Xuzhou Medical University
Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma
The Affiliated Hospital of Xuzhou Medical University
GustaborPilot
Wuerzburg University Hospital
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
The First Affiliated Hospital of Soochow University
DKPD
The First Affiliated Hospital of Soochow University
A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma
The First Affiliated Hospital of Soochow University
LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma
First Affiliated Hospital of Wenzhou Medical University
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Ciusss de L'Est de l'Île de Montréal
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
RenJi Hospital
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
The First Affiliated Hospital with Nanjing Medical University
RAT-HEMATO
University Hospital, Angers